KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Resmed (RMD) Shares Outstanding (Weighted Average) (2016 - 2025)

Resmed's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $145.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 0.68% year-over-year to $145.8 million; the TTM value through Dec 2025 reached $145.8 million, down 0.68%, while the annual FY2025 figure was $146.7 million, 0.21% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $145.8 million in Q4 2025 per RMD's latest filing, roughly flat from $146.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $147.1 million in Q4 2023 to a low of $145.2 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $146.4 million, with a median of $146.7 million recorded in 2022.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.68% in 2021, then dropped 0.68% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $145.8 million in 2021, then rose by 0.6% to $146.7 million in 2022, then increased by 0.29% to $147.1 million in 2023, then decreased by 0.2% to $146.8 million in 2024, then dropped by 0.68% to $145.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Shares Outstanding (Weighted Average) are $145.8 million (Q4 2025), $146.2 million (Q3 2025), and $146.7 million (Q2 2025).